EA201490533A1 - Способы и композиции для определения статуса в отношении курения - Google Patents

Способы и композиции для определения статуса в отношении курения

Info

Publication number
EA201490533A1
EA201490533A1 EA201490533A EA201490533A EA201490533A1 EA 201490533 A1 EA201490533 A1 EA 201490533A1 EA 201490533 A EA201490533 A EA 201490533A EA 201490533 A EA201490533 A EA 201490533A EA 201490533 A1 EA201490533 A1 EA 201490533A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
smoking
status
regard
compositions
Prior art date
Application number
EA201490533A
Other languages
English (en)
Inventor
Стивен Розенберг
Майкл Рид Елашофф
Филлип Байник
Джеймс А. Уингроув
Original Assignee
Кардиодиикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кардиодиикс, Инк. filed Critical Кардиодиикс, Инк.
Publication of EA201490533A1 publication Critical patent/EA201490533A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Data Mining & Analysis (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Изобретение относится к маркерам периферической крови, уровни экспрессии которых коррелируют со статусом в отношении курения. Раскрыты прогностические модели, разработанные при помощи высокоинформативных маркеров, наряду с системами, наборами и способами применения маркеров для получения биохимического идентификатора для статуса в отношении курения у объекта.
EA201490533A 2011-08-29 2012-08-24 Способы и композиции для определения статуса в отношении курения EA201490533A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161528616P 2011-08-29 2011-08-29
PCT/US2012/052303 WO2013032917A2 (en) 2011-08-29 2012-08-24 Methods and compositions for determining smoking status

Publications (1)

Publication Number Publication Date
EA201490533A1 true EA201490533A1 (ru) 2014-08-29

Family

ID=47757128

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490533A EA201490533A1 (ru) 2011-08-29 2012-08-24 Способы и композиции для определения статуса в отношении курения

Country Status (12)

Country Link
US (2) US20150178462A1 (ru)
EP (1) EP2751290A4 (ru)
JP (1) JP2014531202A (ru)
KR (1) KR20140051461A (ru)
CN (1) CN103890193A (ru)
AU (1) AU2012300375A1 (ru)
BR (1) BR112014004768A2 (ru)
CA (1) CA2846837A1 (ru)
EA (1) EA201490533A1 (ru)
IL (1) IL231131A0 (ru)
SG (1) SG11201400243PA (ru)
WO (1) WO2013032917A2 (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103389376B (zh) * 2013-08-21 2015-08-19 中南大学湘雅医院 评估肝细胞癌临床分期和预后的试剂盒及ecscr的应用
WO2015091225A1 (en) * 2013-12-16 2015-06-25 Philip Morris Products S.A. Systems and methods for predicting a smoking status of an individual
CN105214077B (zh) * 2014-06-03 2019-02-05 浙江阿思科力生物科技有限公司 Usp33在肿瘤中的应用
CN106795565B (zh) * 2014-07-14 2022-05-10 威拉赛特公司 用于评估肺癌状态的方法
CN104651354B (zh) * 2015-01-21 2017-12-15 田小利 Scml4基因序列及表达改变检测及其在冠心病预测中的应用
CN107683289B (zh) * 2015-01-26 2021-08-06 芝加哥大学 IL13Rα2结合剂和其在癌症治疗中的用途
CN113854979A (zh) * 2015-04-07 2021-12-31 凯洛特公司 用于吸烟行为的量化和预测的***和方法
CN105296658A (zh) * 2015-11-30 2016-02-03 北京泱深生物信息技术有限公司 Alkbh2基因在缺血性脑卒中诊断中的应用
EP3475911A1 (en) * 2016-06-22 2019-05-01 Swiss Reinsurance Company Ltd. Life insurance system with fully automated underwriting process for real-time underwriting and risk adjustment, and corresponding method thereof
WO2018050299A1 (en) * 2016-09-14 2018-03-22 Philip Morris Products S.A. Systems, methods, and gene signatures for predicting a biological status of an individual
CN106801095A (zh) * 2017-02-14 2017-06-06 徐州市中心医院 Prrt1基因在制备冠心病诊断产品中的应用
CN107937521B (zh) * 2017-11-19 2019-01-04 武汉迈特维尔生物科技有限公司 用于检测肾上腺皮质癌的试剂盒
CN108611413B (zh) * 2018-03-30 2021-10-01 青岛泱深生物医药有限公司 一种帕金森相关生物标志物及其应用
CN108070649A (zh) * 2018-02-07 2018-05-25 北京泱深生物信息技术有限公司 Kcne1基因在诊断慢性阻塞性肺疾病中的应用
CN108303547A (zh) * 2018-02-07 2018-07-20 北京泱深生物信息技术有限公司 一种用于诊断慢性阻塞性肺疾病的分子标志物
RU2690393C1 (ru) * 2018-05-29 2019-06-04 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний" Способ прогнозирования вероятности развития атеросклероза у шахтеров с хроническим пылевым бронхитом
CN109055522A (zh) * 2018-07-03 2018-12-21 吉林大学 C4orf38在制备用于检测或治疗神经性疼痛的产品中的应用
CN111500733B (zh) * 2020-05-27 2022-03-08 中国人民解放军军事科学院军事医学研究院 外周血单核细胞中用于非小细胞肺癌早期诊断的分子标记物
CN111856031B (zh) * 2020-07-21 2023-04-28 国家烟草质量监督检验中心 通过测定外周血中性粒细胞中蛋白的表达来鉴定烟碱暴露的潜在生物标志物的方法
CN114231529B (zh) * 2021-11-17 2023-08-01 中国科学院昆明动物研究所 一种人pkmyt1ar基因及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7102429B2 (en) * 2002-06-28 2006-09-05 Motorola, Inc. RF amplifier with enhanced efficiency
CN1852974A (zh) * 2003-06-09 2006-10-25 密歇根大学董事会 用于治疗和诊断癌症的组合物和方法
CA2528669A1 (en) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
DE102004003612B4 (de) * 2004-01-25 2015-01-08 grapho metronic Meß- und Regeltechnik GmbH Verfahren und Auswertung eines Bildes von einem vorbestimmten Ausschnitt eines Druckerzeugnisses
WO2007103541A2 (en) * 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
WO2008063521A2 (en) * 2006-11-13 2008-05-29 The General Hospital Corporation Gene-based clinical scoring system
US20100119474A1 (en) * 2007-03-06 2010-05-13 Cornell University Chronic obstructive pulmonary disease susceptibility and related compositions and methods
US8825587B2 (en) * 2009-04-14 2014-09-02 Cardiodx, Inc. Predictive models and method for assessing age

Also Published As

Publication number Publication date
EP2751290A4 (en) 2015-07-15
WO2013032917A3 (en) 2013-06-13
BR112014004768A2 (pt) 2019-09-24
US20150178462A1 (en) 2015-06-25
WO2013032917A2 (en) 2013-03-07
IL231131A0 (en) 2014-03-31
SG11201400243PA (en) 2014-03-28
JP2014531202A (ja) 2014-11-27
CN103890193A (zh) 2014-06-25
AU2012300375A1 (en) 2014-03-20
EP2751290A2 (en) 2014-07-09
KR20140051461A (ko) 2014-04-30
CA2846837A1 (en) 2013-03-07
US20190311808A1 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
EA201490533A1 (ru) Способы и композиции для определения статуса в отношении курения
MX340453B (es) Biomarcadores para cancer de pulmon.
UY34824A (es) Nucleósidos de espirooxetano de uracilo
UY34559A (es) Inhibidores de bromodominios
IN2014DN09302A (ru)
UY34206A (es) Anticuerpo monoclonal de interleucina-31
EA201590027A1 (ru) Способы детекции заболеваний или состояний
UY34456A (es) Anticuerpos anti-il-36r
UY34844A (es) Formas sólidas de un compuesto antiviral
UY34697A (es) Métodos para preparar análogos de nucleótidos
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
GB201217271D0 (en) Traffic sensor management
UY34817A (es) Tienopirimidinas
UY34515A (es) Triazolopiridinas sustituidas
UY33930A (es) Inhibidores novedosos de quinasas
UY34818A (es) Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa
EA201390084A1 (ru) Системы и способы создания поверхности в пространстве разлома
UY34027A (es) Inhibidores sustituidos de acetil-coa carboxilasa.
UY34119A (es) Montaje machihembrado de fijación
MX2015017319A (es) Predicción de múltiples en datos de levantamiento.
BR112015009042A8 (pt) Método para identificar uma população de célula renal heterogênea adequada para implantação e/ou desencadeamento de uma resposta regenerativa
UY34473A (es) Ensayo de alto rendimiento de polimorfismo de nucleótido simple
EA201400939A1 (ru) Способ получения медетомидина с использованием хлорацетона
BR112013032210A2 (pt) gerenciamento de erros em dados geográficos
BR112013030122A2 (pt) método para simular uma resposta de um instrumento de perfilagem de poço de nêutrons, meio legível por computador não transitório, e método para perfilagem de poço